Breaking News about Ranbaxy:

Gallery : Ranbaxy

20 images

Sponsored Update

'Accumulate' Sun Pharma; target Rs 646: PL


Sun Pharmaceutical acquired Ranbaxy at an all-stock deal of USD 4 billion, including equity value of USD 3.2 billion and debt of USD 800 million. Per deal, Ranbaxy to merge with Sun Pharma at a stock swap ratio of 0.8:1. This implies 16% dilution in Sun Pharma with addition of 478 million shares at Rs 457/share to Ranbaxy. Additionally, Sun would also assume contingent liability of USD 850 million in forex derivatives which ...
Full article at: Apr 11 2014, 3:24am CDT


Job cut worry for Ranbaxy sales team

Source: Business Standard

Senate Judiciary Cmte Holds Hearing On Comcast-Time Warner Cable Merger
Even as corporate India cheers the Sun Pharma-Ranbaxy merger, an association of medical representatives has cautioned against job cuts in the case of Ranbaxy's sales representatives, estimated at 5,000.Though Sun ha ...
Full article at: Business Standard Apr 9 2014, 2:19pm CDT

More From the Web

With little patience & luck, Daiichi could come good on second bet


Japanese drugmaker Daiichi Sankyo Co, which offloaded its stake in Ranbaxy to Indian generic major Sun Pharmaceutical for $2.02 billion in exchange for a 9 per cent stake in the latter and no cash, might take up to 42 months to recoup its loss from the transaction should luck and patience eventually turn in its favour, and Sun Pharma live up to market expectations as a successful turnaround artist and investor favourite. We worked on simple arithmetic to arrive at this conclusion. ...
Full article at: Apr 9 2014, 1:12pm CDT

Sun denies Ranbaxy deal insider trading suggestions

Source: Scrip News

Biz Stone Signs Copies Of "Things A Little Bird Told Me"
Sun on 9 April informed the Bombay Stock Exchange that the purchase of shares of Ranbaxy by Silverstreet does not violate insider trading rules and that Silverstreet has two partners - both 100% subsidiaries of ...
Full article at: Scrip News Apr 9 2014, 8:05am CDT

Probe Ranbaxy trades ahead of Sun Pharma deal: brokers

Source: NDTV

Indian stock dealers keep a watch on sha
Ranbaxy shares surged 24 per cent in the three trading sessions leading up to the announcement on Monday that Sun Pharmaceutical had agreed t ...
Full article at: NDTV Apr 9 2014, 3:32am CDT

Sun Ranbaxy in focus – SEBI might probe the deal


SEBI is likely to begin a preliminary enquiry into the USD 4 billion merger of Sun Pharma and Ranbaxy. This is actually to check whether any insider norms were violated. Sun Pharma has risen over 20 percent in three days preced ...
Full article at: Apr 8 2014, 10:58pm CDT

Ranbaxy deal a 'great move’ by Sun: Dr Reddy’s Chairman

Source: The Hindu

Bundeswehr Holds Alpine Adventure Camp 2014
G V Prasad, Chairman and CEO of Dr Reddy’s Laboratories Ltd has described the deal for acquisition of Ranbaxy by Sun Pharmaceuticals Industries as a "great move''. In a statement ...
Full article at: The Hindu Apr 7 2014, 4:37am CDT

Latest stories

Al-Qaida Militants Killed Soldiers in Algeria
Al-Qaida Militants Killed Soldiers in Algeria
Al-Qaida militants killed 14 Algerian soldiers on Saturday night in an ambush.
Judy Greer Celebrates her Planet of the Apes Wedding
Judy Greer Celebrates her Planet of the Apes Wedding
Judy Greer celebrated her Planet of the Apes-themed wedding. She is to appear in Dawn of the Planet of the Apes soon.
Emotient's Sentiment Analysis app.for Google Glass
Emotient's Sentiment Analysis app for Google Glass
The app lets you know what people around you are feeling

India’s Sun Pharma Buys Troubled Rival Ranbaxy for $3.2 Billion

Source: The Jakarta Globe

Bundeswehr Holds Alpine Adventure Camp 2014
New Delhi. India’s third-biggest drug company Sun Pharma announced Monday a $3.2-billion deal to buy domestic larger rival Ranbaxy from Daiichi Sankyo, ending the Japanese company’s costly run as owner. Despite Ranbaxy’s huge US safety regulatory problems, Sun Pharmaceutical Industries said the transaction offered “tremendous growth opportunities” thanks to Ranbaxy’s “significant presence” in the US market as well as in India ...
Full article at: The Jakarta Globe Apr 7 2014, 4:22am CDT

Daiichi the only loser in Sun Pharma, Ranbaxy deal: Adige

Source: NDTV

Bundeswehr Holds Alpine Adventure Camp 2014
Ramesh Adige, former executive director of Ranbaxy told NDTV's Prashant Nair that Sun Pharma's acquisition of Ranbaxy for $3.2 billion is a win-win situation for all stakeholders, except Daiichi, ...
Full article at: NDTV Apr 7 2014, 1:57am CDT

Markets open higher; Sun Pharma rallies on Ranbaxy acquisition

Source: Good Returns

Markets opened the day higher despite weak global cues with Sun Pharma rallying following its acquisition of Ranbaxy laboratories. The Sensex was trading higher by 35 points, while the Nif ...
Full article at: Good Returns Apr 6 2014, 11:06pm CDT


The Hottest Photos of Victoria's Secret Fashion Show 2013